Skip to main content
Signal8

Disbrow Joshua R.

SEC insider (Form 3/4/5 filer). CIK 0001566240. Chief Executive Officer at AYTU BIOPHARMA, INC (AYTU) and 1 other issuer. 9 reported Form 4/5 transactions since Sep 2024; latest on Jul 28, 2026. Located in DENVER, CO.

Companies Disbrow Joshua R. has filed insider reports for

  • AYTU BIOPHARMA, INC (AYTU): Director, Officer, Chief Executive Officer
  • ZYNEX INC (ZYXI): Director
Disbrow Joshua R. profile photo

Disbrow Joshua R.

CIK: 0001566240

Transaction Breakdown

Open Market Buys (P)2 (22.2%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)5 (55.6%)

Compensation grants

Other (G, F, J, C, D, …)2 (22.2%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

AYTU BIOPHARMA, INC logo
AYTU

AYTU BIOPHARMA, INC

DirectorOfficer
ZYNEX INC logo
ZYXI

ZYNEX INC

Director

Discretionary Trading P&L

Holdings

Transaction History (9 total)

  • AYTU BIOPHARMA, INC logo
    AYTU

    AYTU BIOPHARMA, INC

    Jul 28, 2026
    Award
    Direct
    30K shares-
  • ZYNEX INC logo
    ZYXI

    ZYNEX INC

    Mar 26, 2026
    Disposition
    Direct
    12.5K shares-
  • ZYNEX INC logo
    ZYXI

    ZYNEX INC

    Mar 26, 2026
    Disposition
    Direct
    89.5K shares-
  • AYTU BIOPHARMA, INC logo
    AYTU

    AYTU BIOPHARMA, INC

    Oct 3, 2025
    Award
    Direct
    31.4K shares-
  • AYTU BIOPHARMA, INC logo
    AYTU

    AYTU BIOPHARMA, INC

    Oct 3, 2025
    Award
    Direct
    22.5K shares-
  • AYTU BIOPHARMA, INC logo
    AYTU

    AYTU BIOPHARMA, INC

    Jun 9, 2025
    Purchase
    Direct
    66.7K shares at avg. $1.50$100K
  • ZYNEX INC logo
    ZYXI

    ZYNEX INC

    May 15, 2025
    Award
    Direct
    10K shares-
  • AYTU BIOPHARMA, INC logo
    AYTU

    AYTU BIOPHARMA, INC

    Feb 28, 2025
    Purchase
    Direct
    15K shares at avg. $1.30$20K
  • AYTU BIOPHARMA, INC logo
    AYTU

    AYTU BIOPHARMA, INC

    Nov 6, 2024
    Award

    Employee Stock Option (Right to Buy)

    Direct
    38K shares-

1-9 of 9